Back to Journals » Drug Design, Development and Therapy » Volume 6

A first-in-man study to evaluate the safety, tolerability, and pharmacokinetics of pasireotide (SOM230), a multireceptor-targeted somatostatin analog, in healthy volunteers

Total article views   HTML views PDF downloads Totals
11,503 Dovepress* 9,672+ 2,023 11,695
PubMed Central* 1,831 798 2,629
Totals 11,503 2,821 14,324
*Since 19 April 2012
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
6 0 0 0 3 3

View citations on PubMed Central and Google Scholar